Principal Scientist/Associate Director of Pharmacology
- Juvena Therapeutics
- Full time
- Redwood City, California
- Posted: January 11, 2023
Position Description
Juvena Therapeutics is seeking a talented scientific strategist and experienced people leader to lead their pharmacology team as well as early preclinical validation of lead candidates. We are searching for an individual who is excited to work as a leader in an intimate and small team focused on the discovery, preclinical validation, and clinical translation of novel biologics for chronic and rare degenerative diseases across multiple therapeutic areas such as neuromuscular, inflammatory, hepatic, and metabolic-related diseases. This position would oversee the in vivo pharmacology efforts at Juvena with a particular focus on preclinical disease model development, design and implementation of in vivo studies. The Principal Scientist/ Associate Director of Pharmacology will work closely with the department heads across data sciences, discovery, nonclinical and clinical teams to expand Juvena’s platform and execute on critical in vivo studies for unraveling secretome biology to develop novel disease-modifying biologics. The Principal Scientist/ Associate Director of Pharmacology will work collaboratively with various functions to establish robust disease model systems to support ongoing projects and validation of protein pharmaceutical drug candidates. Reporting to the SVP of Discovery, the Principal Scientist/ Associate Director of Pharmacology will be involved in diverse drug candidates in Juvena’s pipeline as well as establishing external R&D partnerships with academic institutions and technology providers.
*Title commensurate with experience.
Company Summary
Juvena Therapeutics is on a mission to discover and develop biologics for rare and chronic degenerative diseases by mining the secretomes of human pluripotent stem cells through a machine learning (ML)-enhanced platform. Juvena’s approach integrates proteomics, transcriptomics and imaging with phenotypic human in vitro disease model screening and extensive preclinical validation to mine stem cell secretomes as a rich source of new medicines for chronic and rare diseases. We are advancing leads for muscular dystrophies, muscle atrophy, injury, and osteopathies. Since our launch in mid-2018, Juvena has discovered 17 hits for neuromuscular and skeletal diseases, including several muscle regenerative protein therapeutic candidates with potent human in vitro and mice in vivo efficacy. Juvena is advancing a lead program for Myotonic Dystrophy Type 1, a rare autosomal dominant, progressive muscle-wasting disease.
Juvena Therapeutics has secured venture capital, NIH, and CIRM funding to develop their top lead to a clinical-stage investigational new drug, to build their stem cell secretome database, and to leverage their discovery platform to rapidly identify and validate novel protein-based drug candidates for multiple rare and chronic diseases across inflammatory, cardiometabolic and hepatic therapeutic areas. At Juvena we embrace a diversity of backgrounds, experiences, and approaches that all combine to lead us to world-class scientific results in an inclusive environment.
Major Responsibilities
Position Requirements and Experience
Preferred Qualifications
Compensation and Benefits